| REGISTERED NUMBER: |
| Strategic Report, Report of the Directors and |
| Financial Statements for the Year Ended 31 March 2025 |
| for |
| Nationwide Healthcare Providers Limited |
| REGISTERED NUMBER: |
| Strategic Report, Report of the Directors and |
| Financial Statements for the Year Ended 31 March 2025 |
| for |
| Nationwide Healthcare Providers Limited |
| Nationwide Healthcare Providers Limited (Registered number: 07474135) |
| Contents of the Financial Statements |
| for the Year Ended 31 March 2025 |
| Page |
| Company Information | 1 |
| Strategic Report | 2 |
| Report of the Directors | 3 |
| Report of the Independent Auditors | 4 |
| Income Statement | 8 |
| Balance Sheet | 9 |
| Statement of Changes in Equity | 10 |
| Cash Flow Statement | 11 |
| Notes to the Cash Flow Statement | 12 |
| Notes to the Financial Statements | 14 |
| Nationwide Healthcare Providers Limited |
| Company Information |
| for the Year Ended 31 March 2025 |
| DIRECTORS: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| AUDITORS: |
| Statutory Auditor |
| Park House |
| 37 Clarence Street |
| Leicester |
| Leicestershire |
| LE1 3RW |
| Nationwide Healthcare Providers Limited (Registered number: 07474135) |
| Strategic Report |
| for the Year Ended 31 March 2025 |
| The directors present their strategic report for the year ended 31 March 2025. |
| REVIEW OF BUSINESS |
| The directors are pleased with the results for the year and are satisfied with the position at the year end. The business has generated increased profit in the financial year through investment in additional surgeries. |
| PRINCIPAL RISKS AND UNCERTAINTIES |
| The directors consider the biggest threat to the business to be changes to recruitment resulting from Brexit. These changes could impact on the quantum of delivery of dental services. |
| KEY PERFORMANCE INDICATORS |
| The directors assess the performance of the business using the following financial key performance indicators: turnover, gross profit, profit before tax, cash and net assets. All of this information can be obtained from the financial statements. |
| FUTURE DEVELOPMENTS |
| The directors are confident that the demand for high quality dental services will continue and they are confident that they are well placed to deliver this service. |
| ON BEHALF OF THE BOARD: |
| Nationwide Healthcare Providers Limited (Registered number: 07474135) |
| Report of the Directors |
| for the Year Ended 31 March 2025 |
| The directors present their report with the financial statements of the company for the year ended 31 March 2025. |
| DIVIDENDS |
| No dividends will be distributed for the year ended 31 March 2025. |
| DIRECTORS |
| The directors shown below have held office during the whole of the period from 1 April 2024 to the date of this report. |
| Other changes in directors holding office are as follows: |
| STATEMENT OF DIRECTORS' RESPONSIBILITIES |
| The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations. |
| Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to: |
| - | select suitable accounting policies and then apply them consistently; |
| - | make judgements and accounting estimates that are reasonable and prudent; |
| - | prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. |
| The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. |
| STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS |
| So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information. |
| ON BEHALF OF THE BOARD: |
| Report of the Independent Auditors to the Members of |
| Nationwide Healthcare Providers Limited |
| Opinion |
| We have audited the financial statements of Nationwide Healthcare Providers Limited (the 'company') for the year ended 31 March 2025 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice). |
| In our opinion the financial statements: |
| - | give a true and fair view of the state of the company's affairs as at 31 March 2025 and of its profit for the year then ended; |
| - | have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and |
| - | have been prepared in accordance with the requirements of the Companies Act 2006. |
| Basis for opinion |
| We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. |
| Conclusions relating to going concern |
| In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. |
| Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. |
| Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report. |
| Other information |
| The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon. |
| Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. |
| In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard. |
| Opinions on other matters prescribed by the Companies Act 2006 |
| In our opinion, based on the work undertaken in the course of the audit: |
| - | the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and |
| - | the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements. |
| Report of the Independent Auditors to the Members of |
| Nationwide Healthcare Providers Limited |
| Matters on which we are required to report by exception |
| In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors. |
| We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion: |
| - | adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or |
| - | the financial statements are not in agreement with the accounting records and returns; or |
| - | certain disclosures of directors' remuneration specified by law are not made; or |
| - | we have not received all the information and explanations we require for our audit. |
| Responsibilities of directors |
| As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. |
| In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so. |
| Report of the Independent Auditors to the Members of |
| Nationwide Healthcare Providers Limited |
| Auditors' responsibilities for the audit of the financial statements |
| Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. |
| The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below: |
| Extent to which the audit was considered capable of detecting irregularities, including fraud |
| The capability to detect irregularities is based on the auditor identifying and assessing the risks of material misstatement of the financial statements, whether due to fraud or error, and then designing and performing audit procedures responsive to those risks, including obtaining audit evidence that is sufficient and appropriate to provide a basis for our opinion. |
| a) Identifying and assessing potential risks related to irregularities |
| In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, the following approach was taken: |
| - | Understanding the nature of the industry and sector, control environment and business performance; |
| - | Consideration of the results of our enquiries of management and those charged with governance about their own identification and assessment of the risks of irregularities; |
| - | Understanding the company's policies and procedures on compliance with laws and regulations and management of fraud risk, including documentation of instances of non-compliance of laws and regulations and instances of actual, suspected or alleged fraud; |
| - | Consideration of matters discussed among the audit engagement team regarding how and where fraud might occur in the financial statements and any potential indicators of fraud; |
| - | Understanding the legal and regulatory frameworks that the company operates in through enquiry of management and those charged with governance and understanding the company's industry and sector. The key laws and regulations that were considered to have an effect on material amounts and disclosures in the financial statements included the Companies Act and tax legislation. |
| b) Audit response to risks identified |
| Based on this understanding, the following audit procedures were designed and performed to respond to the risks identified: |
| - | Reviewing the financial statement disclosures and testing to supporting documentation to assess compliance with applicable laws and regulations described as having a direct effect on the financial statement; |
| - | Enquiring of management, those charged with governance and, where applicable, the company's solicitors concerning actual and potential litigation and claims; |
| - | Performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud; |
| - | Reviewing minutes of meetings of those charged with governance and, where applicable, correspondence with regulators; |
| - | Performing audit work over the risk of management override of controls, including testing of journal entries and other adjustments for appropriateness and evaluating the business rationale of significant transactions outside the normal course of business; |
| - | Communication of potential fraud risks to all engagement team members and remaining alert to any indications of fraud or non-compliance with laws and regulations throughout the audit. |
| Report of the Independent Auditors to the Members of |
| Nationwide Healthcare Providers Limited |
| Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation. |
| A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors. |
| Use of our report |
| This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed. |
| for and on behalf of |
| Statutory Auditor |
| Park House |
| 37 Clarence Street |
| Leicester |
| Leicestershire |
| LE1 3RW |
| Nationwide Healthcare Providers Limited (Registered number: 07474135) |
| Income Statement |
| for the Year Ended 31 March 2025 |
| 31.3.25 | 31.3.24 |
| Notes | £ | £ |
| TURNOVER |
| Cost of sales | ( |
) | ( |
) |
| GROSS PROFIT |
| Administrative expenses | ( |
) | ( |
) |
| 7,086,848 | 3,169,966 |
| Other operating income |
| OPERATING PROFIT | 4 |
| Interest receivable and similar income |
| 7,192,315 | 3,177,208 |
| Interest payable and similar expenses | 5 | ( |
) | ( |
) |
| PROFIT BEFORE TAXATION |
| Tax on profit | 6 | ( |
) | ( |
) |
| PROFIT FOR THE FINANCIAL YEAR |
| Nationwide Healthcare Providers Limited (Registered number: 07474135) |
| Balance Sheet |
| 31 March 2025 |
| 31.3.25 | 31.3.24 |
| Notes | £ | £ |
| FIXED ASSETS |
| Intangible assets | 7 |
| Tangible assets | 8 |
| CURRENT ASSETS |
| Stocks | 9 |
| Debtors | 10 |
| Cash at bank and in hand |
| CREDITORS |
| Amounts falling due within one year | 11 | ( |
) | ( |
) |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CREDITORS |
| Amounts falling due after more than one year |
12 |
( |
) |
( |
) |
| PROVISIONS FOR LIABILITIES | 16 | ( |
) | ( |
) |
| NET ASSETS |
| CAPITAL AND RESERVES |
| Called up share capital | 17 |
| Retained earnings | 18 |
| SHAREHOLDERS' FUNDS |
| The financial statements were approved by the Board of Directors and authorised for issue on |
| Nationwide Healthcare Providers Limited (Registered number: 07474135) |
| Statement of Changes in Equity |
| for the Year Ended 31 March 2025 |
| Called up |
| share | Retained | Total |
| capital | earnings | equity |
| £ | £ | £ |
| Balance at 1 April 2023 |
| Changes in equity |
| Total comprehensive income | - |
| Balance at 31 March 2024 |
| Changes in equity |
| Total comprehensive income | - |
| Balance at 31 March 2025 |
| Nationwide Healthcare Providers Limited (Registered number: 07474135) |
| Cash Flow Statement |
| for the Year Ended 31 March 2025 |
| 31.3.25 | 31.3.24 |
| Notes | £ | £ |
| Cash flows from operating activities |
| Cash generated from operations | 1 |
| Interest paid | ( |
) | ( |
) |
| Tax paid | ( |
) | ( |
) |
| Net cash from operating activities |
| Cash flows from investing activities |
| Purchase of intangible fixed assets | ( |
) | ( |
) |
| Purchase of tangible fixed assets | ( |
) | ( |
) |
| Sale of tangible fixed assets |
| Interest received |
| Net cash from investing activities | ( |
) | ( |
) |
| Cash flows from financing activities |
| Loan repayments in year | ( |
) | ( |
) |
| Amount introduced by directors | 471,013 | - |
| Amount withdrawn by directors | - | (564,738 | ) |
| Net cash from financing activities | ( |
) |
| Increase/(decrease) in cash and cash equivalents | ( |
) |
| Cash and cash equivalents at beginning of year |
2 |
74,957 |
2,362,862 |
| Cash and cash equivalents at end of year |
2 |
1,140,002 |
| Nationwide Healthcare Providers Limited (Registered number: 07474135) |
| Notes to the Cash Flow Statement |
| for the Year Ended 31 March 2025 |
| 1. | RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS |
| 31.3.25 | 31.3.24 |
| £ | £ |
| Profit before taxation |
| Depreciation charges |
| Finance costs | 130,520 | 67,501 |
| Finance income | (68,647 | ) | (4,902 | ) |
| 7,607,079 | 3,527,899 |
| Increase in stocks | ( |
) |
| Increase in trade and other debtors | ( |
) | ( |
) |
| Increase in trade and other creditors |
| Cash generated from operations |
| 2. | CASH AND CASH EQUIVALENTS |
| The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts: |
| Year ended 31 March 2025 |
| 31.3.25 | 1.4.24 |
| £ | £ |
| Cash and cash equivalents | 1,140,002 | 85,724 |
| Bank overdrafts | ( |
) |
| 1,140,002 | 74,957 |
| Year ended 31 March 2024 |
| 31.3.24 | 1.4.23 |
| £ | £ |
| Cash and cash equivalents | 85,724 | 2,362,862 |
| Bank overdrafts | ( |
) |
| 74,957 | 2,362,862 |
| Nationwide Healthcare Providers Limited (Registered number: 07474135) |
| Notes to the Cash Flow Statement |
| for the Year Ended 31 March 2025 |
| 3. | ANALYSIS OF CHANGES IN NET DEBT |
| At 1.4.24 | Cash flow | At 31.3.25 |
| £ | £ | £ |
| Net cash |
| Cash at bank and in hand | 85,724 | 1,054,278 | 1,140,002 |
| Bank overdrafts | (10,767 | ) | 10,767 | - |
| 74,957 | 1,140,002 |
| Debt |
| Debts falling due within 1 year | (185,988 | ) | 54,222 | (131,766 | ) |
| Debts falling due after 1 year | (1,828,056 | ) | 135,185 | (1,692,871 | ) |
| (2,014,044 | ) | 189,407 | (1,824,637 | ) |
| Total | (1,939,087 | ) | 1,254,452 | (684,635 | ) |
| Nationwide Healthcare Providers Limited (Registered number: 07474135) |
| Notes to the Financial Statements |
| for the Year Ended 31 March 2025 |
| 1. | STATUTORY INFORMATION |
| Nationwide Healthcare Providers Limited is a |
| The presentation currency of the financial statements is the Pound Sterling (£). |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| Turnover |
| Turnover comprises revenue recognised by the company in respect of dental services provided during the period and is recognised at the point the service is supplied. |
| Goodwill |
| Goodwill is the difference between amounts paid on the acquisitions of a business and the fair value of the identifiable assets and liabilities. It is amortised in the profit and loss account over its estimated useful life of 10 years. |
| Tangible fixed assets |
| Freehold property | - |
| Dental equipment | - |
| Fixtures and fittings | - |
| Motor vehicles | - |
| Computer equipment | - |
| The expected useful lives of assets are reviewed and adjusted, if appropriate, at the end of each |
| reporting period. The effect of any change is accounted for prospectively. |
| Stocks |
| Stocks are valued at the lower of cost and estimated selling price less costs to complete and sell, after making due allowance for obsolete and slow moving items. |
| At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss. |
| Taxation |
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
| Current or deferred taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
| Nationwide Healthcare Providers Limited (Registered number: 07474135) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 March 2025 |
| 2. | ACCOUNTING POLICIES - continued |
| Deferred tax |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
| Hire purchase and leasing commitments |
| Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease. |
| Pension costs and other post-retirement benefits |
| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate. |
| 3. | EMPLOYEES AND DIRECTORS |
| 31.3.25 | 31.3.24 |
| £ | £ |
| Wages and salaries |
| Social security costs |
| Other pension costs |
| The average number of employees during the year was as follows: |
| 31.3.25 | 31.3.24 |
| Directors | 3 | 3 |
| Other employees | 269 | 213 |
| 31.3.25 | 31.3.24 |
| £ | £ |
| Directors' remuneration |
| 4. | OPERATING PROFIT |
| The operating profit is stated after charging: |
| 31.3.25 | 31.3.24 |
| £ | £ |
| Other operating leases |
| Depreciation - owned assets |
| Goodwill amortisation |
| Auditors' remuneration |
| Nationwide Healthcare Providers Limited (Registered number: 07474135) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 March 2025 |
| 5. | INTEREST PAYABLE AND SIMILAR EXPENSES |
| 31.3.25 | 31.3.24 |
| £ | £ |
| Bank loan interest |
| 6. | TAXATION |
| Analysis of the tax charge |
| The tax charge on the profit for the year was as follows: |
| 31.3.25 | 31.3.24 |
| £ | £ |
| Current tax: |
| UK corporation tax |
| Corporation tax - prior year | (1,471 | ) | - |
| Total current tax |
| Deferred tax |
| Tax on profit |
| UK corporation tax has been charged at 25% (2024 - 25%). |
| Reconciliation of total tax charge included in profit and loss |
| The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below: |
| 31.3.25 | 31.3.24 |
| £ | £ |
| Profit before tax |
| Profit multiplied by the standard rate of corporation tax in the UK of |
| Effects of: |
| Expenses not deductible for tax purposes |
| Adjustments to tax charge in respect of previous periods | ( |
) |
| Total tax charge | 1,816,569 | 848,334 |
| Nationwide Healthcare Providers Limited (Registered number: 07474135) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 March 2025 |
| 7. | INTANGIBLE FIXED ASSETS |
| Goodwill |
| £ |
| COST |
| At 1 April 2024 |
| Additions |
| At 31 March 2025 |
| AMORTISATION |
| At 1 April 2024 |
| Amortisation for year |
| At 31 March 2025 |
| NET BOOK VALUE |
| At 31 March 2025 |
| At 31 March 2024 |
| 8. | TANGIBLE FIXED ASSETS |
| Fixtures |
| Freehold | Dental | and |
| property | equipment | fittings |
| £ | £ | £ |
| COST |
| At 1 April 2024 |
| Additions |
| At 31 March 2025 |
| DEPRECIATION |
| At 1 April 2024 |
| Charge for year |
| At 31 March 2025 |
| NET BOOK VALUE |
| At 31 March 2025 |
| At 31 March 2024 |
| Nationwide Healthcare Providers Limited (Registered number: 07474135) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 March 2025 |
| 8. | TANGIBLE FIXED ASSETS - continued |
| Motor | Computer |
| vehicles | equipment | Totals |
| £ | £ | £ |
| COST |
| At 1 April 2024 |
| Additions |
| At 31 March 2025 |
| DEPRECIATION |
| At 1 April 2024 |
| Charge for year |
| At 31 March 2025 |
| NET BOOK VALUE |
| At 31 March 2025 |
| At 31 March 2024 |
| 9. | STOCKS |
| 31.3.25 | 31.3.24 |
| £ | £ |
| Stocks |
| Stock recognised in cost of sales during the year as an expense was £1,934,157 (2024: £1,960,730) |
| 10. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 31.3.25 | 31.3.24 |
| £ | £ |
| Trade debtors |
| Other debtors |
| Directors' current accounts | 93,725 | 564,738 |
| Corporation tax |
| Prepayments and accrued income |
| Included within other debtors are amounts due after 1 year of £898,130 (2024 - £1,073,435) |
| 11. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 31.3.25 | 31.3.24 |
| £ | £ |
| Bank loans and overdrafts (see note 13) |
| Trade creditors |
| Corporation tax |
| Social security and other taxes |
| Other creditors |
| Accruals and deferred income |
| Nationwide Healthcare Providers Limited (Registered number: 07474135) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 March 2025 |
| 12. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |
| 31.3.25 | 31.3.24 |
| £ | £ |
| Bank loans (see note 13) |
| 13. | LOANS |
| An analysis of the maturity of loans is given below: |
| 31.3.25 | 31.3.24 |
| £ | £ |
| Amounts falling due within one year or on demand: |
| Bank overdrafts |
| Bank loans |
| Amounts falling due between two and five years: |
| Bank loans - 2-5 years |
| Amounts falling due in more than five years: |
| Repayable by instalments |
| Bank loans > 5 years by instalments | 1,132,679 | 1,202,566 |
| Bank loans are repayable in instalments over 15 years and interest is charged at 1.9% over the Bank of England base rate. |
| 14. | LEASING AGREEMENTS |
| Minimum lease payments under non-cancellable operating leases fall due as follows: |
| 31.3.25 | 31.3.24 |
| £ | £ |
| Within one year |
| Between one and five years |
| 15. | SECURED DEBTS |
| The following secured debts are included within creditors: |
| 31.3.25 | 31.3.24 |
| £ | £ |
| Bank overdraft |
| Bank loans |
| Bank loans and overdrafts are secured by fixed and floating charge over all assets of the company and guaranteed by related parties. |
| Nationwide Healthcare Providers Limited (Registered number: 07474135) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 March 2025 |
| 16. | PROVISIONS FOR LIABILITIES |
| 31.3.25 | 31.3.24 |
| £ | £ |
| Deferred tax |
| Accelerated capital allowances |
| Other timing differences | - | (883 | ) |
| 323,784 | 216,182 |
| Deferred |
| tax |
| £ |
| Balance at 1 April 2024 |
| Charge to Income Statement during year |
| Balance at 31 March 2025 |
| 17. | CALLED UP SHARE CAPITAL |
| Allotted, issued and fully paid: |
| Number: | Class: | Nominal | 31.3.25 | 31.3.24 |
| value: | £ | £ |
| Ordinary | £1 | 10,000,000 | 10,000,000 |
| Ordinary shares carry one vote per share and equal rights to dividends. |
| 18. | RESERVES |
| Retained |
| earnings |
| £ |
| At 1 April 2024 |
| Profit for the year |
| At 31 March 2025 |
| 19. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES |
| The following advances and credits to a director subsisted during the years ended 31 March 2025 and 31 March 2024: |
| 31.3.25 | 31.3.24 |
| £ | £ |
| Balance outstanding at start of year |
| Amounts advanced |
| Amounts repaid | ( |
) |
| Amounts written off | - | - |
| Amounts waived | - | - |
| Balance outstanding at end of year |
| The loan is repayable upon demand and interest is charged at HMRC's official rate of interest. |
| 20. | RELATED PARTY DISCLOSURES |
| Nationwide Healthcare Providers Limited (Registered number: 07474135) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 March 2025 |
| 20. | RELATED PARTY DISCLOSURES - continued |
| Key management personnel of the entity or its parent (in the aggregate) |
| 31.3.25 | 31.3.24 |
| £ | £ |
| Purchase of clinical services |
| Amount due from related party | 93,725 | 564,738 |
| Amount due to related party | 30,432 | 31,338 |
| Bank loans and overdrafts are secured by way of a personal guarantee from key management personnel. |
| Key management personnel are considered to be the directors of the company and their remuneration is disclosed in note 3. |
| 31.3.25 | 31.3.24 |
| £ | £ |
| Rent paid | 440,400 | 469,200 |
| Interest received | 68,647 | 71,372 |
| Amount due from related party | 27,278,255 | 18,929,229 |
| Amount due to related party | 2,692,294 | 4,318,826 |
| Bank loans and overdrafts are secured by way of a guarantee from other related parties. |
| Other related parties are companies under common control. |
| 21. | ULTIMATE CONTROLLING PARTY |
| During the year the company was controlled by J Ahmad. At the date of approval of these financial statements there was no ultimate controlling party. |